Preliminary Assessment of Safety and Tolerability of Avacopan During the Early Access Program for ANCA-Associated Vasculitis.
Jolijn R van LeeuwenTamara PopovAchim ObergfellTon J RabelinkY K Onno TengPublished in: Biologics : targets & therapy (2023)